Anti-CarP antibodies as promising marker to measure joint damage and disease activity in patients with rheumatoid arthritis

Alvin Yee, Tyler Webb, Andrea Seaman, Maria Infantino, Francesca Meacci, Mariangela Manfredi, Maurizio Benucci, Gabriella Lakos, Ennio Favalli, Tommaso Shioppo, Pier Luigi Meroni, Michael Mahler

Research output: Contribution to journalArticle

Abstract

Anti-citrullinated protein antibodies (ACPA) are important serological markers in the diagnosis of rheumatoid arthritis (RA) and are part of the recent disease classification criteria. However, there is a strong need for reliable markers for measuring and predicting joint damage and disease activity. Recently, antibodies directed against carbamylated antigens (anti-CarP antibodies) were identified. A total of 120 RA patients were tested for anti-CCP antibodies using different methods and for anti-CarP antibodies using carbamylated fetal calf serum according to the method described by Shi et al. Additionally, ACPA fine specificities (to three citrullinated peptides) were measured. Disease activity was assessed at baseline using the disease activity score 28 (DAS28) in 80 patients. For 40 RA patients, joint erosion score (JES) was established. The median JES was 14.1 with a standard deviation of 11.5. Anti-CarP antibodies were correlated with joint erosion score (ρ = 0.34, 95 % CI 0.03–0.59; p = 0.0332). No correlation between ACPA and joint erosion score was observed. No individual marker correlated with DAS28. When one ACPA peptide was combined with anti-CarP antibodies in a score (ACPA peptide 1 divided by anti-CarP), a statistically relevant correlation was found (p = 0.0264). In this small cohort, the presence of anti-CarP antibodies, but not ACPA correlate with joint erosion score. Anti-CarP antibodies combined with ACPA fine specificities correlated with DAS28. Therefore, anti-CarP antibodies might represent a promising marker to predict joint damage and disease activity in RA patients.

Original languageEnglish
Pages (from-to)24-30
Number of pages7
JournalImmunologic Research
Volume61
Issue number1-2
DOIs
Publication statusPublished - 2014

Fingerprint

Carps
Joint Diseases
Anti-Idiotypic Antibodies
Rheumatoid Arthritis
Joints
Antibodies
Proteins
Antibody Specificity
Peptides
Antigens
Serum

Keywords

  • Autoantibodies
  • CarP
  • CCP
  • Citrullinated cyclic peptide
  • Homocitrulline
  • RA
  • Rheumatoid arthritis

ASJC Scopus subject areas

  • Immunology
  • Medicine(all)

Cite this

Anti-CarP antibodies as promising marker to measure joint damage and disease activity in patients with rheumatoid arthritis. / Yee, Alvin; Webb, Tyler; Seaman, Andrea; Infantino, Maria; Meacci, Francesca; Manfredi, Mariangela; Benucci, Maurizio; Lakos, Gabriella; Favalli, Ennio; Shioppo, Tommaso; Meroni, Pier Luigi; Mahler, Michael.

In: Immunologic Research, Vol. 61, No. 1-2, 2014, p. 24-30.

Research output: Contribution to journalArticle

Yee, A, Webb, T, Seaman, A, Infantino, M, Meacci, F, Manfredi, M, Benucci, M, Lakos, G, Favalli, E, Shioppo, T, Meroni, PL & Mahler, M 2014, 'Anti-CarP antibodies as promising marker to measure joint damage and disease activity in patients with rheumatoid arthritis', Immunologic Research, vol. 61, no. 1-2, pp. 24-30. https://doi.org/10.1007/s12026-014-8560-x
Yee, Alvin ; Webb, Tyler ; Seaman, Andrea ; Infantino, Maria ; Meacci, Francesca ; Manfredi, Mariangela ; Benucci, Maurizio ; Lakos, Gabriella ; Favalli, Ennio ; Shioppo, Tommaso ; Meroni, Pier Luigi ; Mahler, Michael. / Anti-CarP antibodies as promising marker to measure joint damage and disease activity in patients with rheumatoid arthritis. In: Immunologic Research. 2014 ; Vol. 61, No. 1-2. pp. 24-30.
@article{70d606c6dac242e7a7982d3e3784a29d,
title = "Anti-CarP antibodies as promising marker to measure joint damage and disease activity in patients with rheumatoid arthritis",
abstract = "Anti-citrullinated protein antibodies (ACPA) are important serological markers in the diagnosis of rheumatoid arthritis (RA) and are part of the recent disease classification criteria. However, there is a strong need for reliable markers for measuring and predicting joint damage and disease activity. Recently, antibodies directed against carbamylated antigens (anti-CarP antibodies) were identified. A total of 120 RA patients were tested for anti-CCP antibodies using different methods and for anti-CarP antibodies using carbamylated fetal calf serum according to the method described by Shi et al. Additionally, ACPA fine specificities (to three citrullinated peptides) were measured. Disease activity was assessed at baseline using the disease activity score 28 (DAS28) in 80 patients. For 40 RA patients, joint erosion score (JES) was established. The median JES was 14.1 with a standard deviation of 11.5. Anti-CarP antibodies were correlated with joint erosion score (ρ = 0.34, 95 {\%} CI 0.03–0.59; p = 0.0332). No correlation between ACPA and joint erosion score was observed. No individual marker correlated with DAS28. When one ACPA peptide was combined with anti-CarP antibodies in a score (ACPA peptide 1 divided by anti-CarP), a statistically relevant correlation was found (p = 0.0264). In this small cohort, the presence of anti-CarP antibodies, but not ACPA correlate with joint erosion score. Anti-CarP antibodies combined with ACPA fine specificities correlated with DAS28. Therefore, anti-CarP antibodies might represent a promising marker to predict joint damage and disease activity in RA patients.",
keywords = "Autoantibodies, CarP, CCP, Citrullinated cyclic peptide, Homocitrulline, RA, Rheumatoid arthritis",
author = "Alvin Yee and Tyler Webb and Andrea Seaman and Maria Infantino and Francesca Meacci and Mariangela Manfredi and Maurizio Benucci and Gabriella Lakos and Ennio Favalli and Tommaso Shioppo and Meroni, {Pier Luigi} and Michael Mahler",
year = "2014",
doi = "10.1007/s12026-014-8560-x",
language = "English",
volume = "61",
pages = "24--30",
journal = "Immunologic Research",
issn = "0257-277X",
publisher = "Humana Press",
number = "1-2",

}

TY - JOUR

T1 - Anti-CarP antibodies as promising marker to measure joint damage and disease activity in patients with rheumatoid arthritis

AU - Yee, Alvin

AU - Webb, Tyler

AU - Seaman, Andrea

AU - Infantino, Maria

AU - Meacci, Francesca

AU - Manfredi, Mariangela

AU - Benucci, Maurizio

AU - Lakos, Gabriella

AU - Favalli, Ennio

AU - Shioppo, Tommaso

AU - Meroni, Pier Luigi

AU - Mahler, Michael

PY - 2014

Y1 - 2014

N2 - Anti-citrullinated protein antibodies (ACPA) are important serological markers in the diagnosis of rheumatoid arthritis (RA) and are part of the recent disease classification criteria. However, there is a strong need for reliable markers for measuring and predicting joint damage and disease activity. Recently, antibodies directed against carbamylated antigens (anti-CarP antibodies) were identified. A total of 120 RA patients were tested for anti-CCP antibodies using different methods and for anti-CarP antibodies using carbamylated fetal calf serum according to the method described by Shi et al. Additionally, ACPA fine specificities (to three citrullinated peptides) were measured. Disease activity was assessed at baseline using the disease activity score 28 (DAS28) in 80 patients. For 40 RA patients, joint erosion score (JES) was established. The median JES was 14.1 with a standard deviation of 11.5. Anti-CarP antibodies were correlated with joint erosion score (ρ = 0.34, 95 % CI 0.03–0.59; p = 0.0332). No correlation between ACPA and joint erosion score was observed. No individual marker correlated with DAS28. When one ACPA peptide was combined with anti-CarP antibodies in a score (ACPA peptide 1 divided by anti-CarP), a statistically relevant correlation was found (p = 0.0264). In this small cohort, the presence of anti-CarP antibodies, but not ACPA correlate with joint erosion score. Anti-CarP antibodies combined with ACPA fine specificities correlated with DAS28. Therefore, anti-CarP antibodies might represent a promising marker to predict joint damage and disease activity in RA patients.

AB - Anti-citrullinated protein antibodies (ACPA) are important serological markers in the diagnosis of rheumatoid arthritis (RA) and are part of the recent disease classification criteria. However, there is a strong need for reliable markers for measuring and predicting joint damage and disease activity. Recently, antibodies directed against carbamylated antigens (anti-CarP antibodies) were identified. A total of 120 RA patients were tested for anti-CCP antibodies using different methods and for anti-CarP antibodies using carbamylated fetal calf serum according to the method described by Shi et al. Additionally, ACPA fine specificities (to three citrullinated peptides) were measured. Disease activity was assessed at baseline using the disease activity score 28 (DAS28) in 80 patients. For 40 RA patients, joint erosion score (JES) was established. The median JES was 14.1 with a standard deviation of 11.5. Anti-CarP antibodies were correlated with joint erosion score (ρ = 0.34, 95 % CI 0.03–0.59; p = 0.0332). No correlation between ACPA and joint erosion score was observed. No individual marker correlated with DAS28. When one ACPA peptide was combined with anti-CarP antibodies in a score (ACPA peptide 1 divided by anti-CarP), a statistically relevant correlation was found (p = 0.0264). In this small cohort, the presence of anti-CarP antibodies, but not ACPA correlate with joint erosion score. Anti-CarP antibodies combined with ACPA fine specificities correlated with DAS28. Therefore, anti-CarP antibodies might represent a promising marker to predict joint damage and disease activity in RA patients.

KW - Autoantibodies

KW - CarP

KW - CCP

KW - Citrullinated cyclic peptide

KW - Homocitrulline

KW - RA

KW - Rheumatoid arthritis

UR - http://www.scopus.com/inward/record.url?scp=84925518142&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84925518142&partnerID=8YFLogxK

U2 - 10.1007/s12026-014-8560-x

DO - 10.1007/s12026-014-8560-x

M3 - Article

C2 - 25391608

AN - SCOPUS:84925518142

VL - 61

SP - 24

EP - 30

JO - Immunologic Research

JF - Immunologic Research

SN - 0257-277X

IS - 1-2

ER -